Z-Z Wang
Overview
Explore the profile of Z-Z Wang including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
19
Citations
406
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Ma G, Zou L, Dai W, Wang Z, Cao Y
Eur Rev Med Pharmacol Sci
. 2023 Mar;
27(5):1912-1920.
PMID: 36930518
Objective: Growing evidence shows that sarcopenia is more prevalent in patients with type 2 diabetes mellitus (T2DM) than in the normal population. However, currently, data on the relationship between blood...
2.
Tian L, Zhang J, Wang Z, Chen S, Zou X, Yu Z, et al.
Eur Rev Med Pharmacol Sci
. 2020 Nov;
24(20):10819-10828.
PMID: 33155243
Objective: Sepsis-induced acute liver injury (ALI) involves multiple systems in the body. The disease is acute and critical, with various symptoms, including extensive necrosis of liver cells. There is currently...
3.
Wang Z, Chen S, Zou X, Tian L, Sui S, Liu N
Eur Rev Med Pharmacol Sci
. 2020 May;
24(9):5071-5081.
PMID: 32432771
Objective: Acute lung injury (ALI) is the most common complication of sepsis, with rapid onset and high mortality. There is currently no effective treatment for ALI. Therefore, we looked for...
4.
Li C, Jia L, Gao J, Wang Z, An X
Eur Rev Med Pharmacol Sci
. 2019 Sep;
23(16):7144-7151.
PMID: 31486517
Objective: This study aimed to compare the efficacy and safety of ulinastatin combined with creatine phosphate sodium and ribavirin combined with creatine phosphate sodium in the treatment of pediatric viral...
5.
Wang Z, Luo Y, Du J, Yu Y, Yang X, Cui Y, et al.
Eur Rev Med Pharmacol Sci
. 2019 Jul;
23(12):5206-5214.
PMID: 31298412
Objective: Many studies have emphasized the function of microRNA-296 (miR-296) that inhibits tumor formation. To some extent, the role of miR-296 in esophageal squamous cell carcinoma (ESCC) remains misleading. Therefore,...
6.
Ling N, Li C, Wang Z, Zhang H, Xu H, An X
Eur Rev Med Pharmacol Sci
. 2018 Mar;
22(4):1102-1105.
PMID: 29509262
Objective: We aimed to investigate the heart rate variability in children with myocarditis presenting with ventricular arrhythmias. Patients And Methods: The study compared the characteristics of heart rate variability (HRV)...
7.
He X, Li C, Ling N, Wang Q, Wang Z, An X
Eur Rev Med Pharmacol Sci
. 2017 Aug;
21(15):3447-3451.
PMID: 28829496
Objective: We analyzed the relationship between Mink-S27 gene polymorphism and children with cardiac insufficiency. Patients And Methods: From April 2013 to April 2015, we enrolled 73 cases of children with...
8.
Wang Y, Zhao Y, Zhang A, Ma J, Wang Z, Zhang X
Eur Rev Med Pharmacol Sci
. 2017 Jul;
21(13):2980.
PMID: 28742211
The article "Targeting of miR-20a against CFLAR to potentiate TRAIL-induced apoptotic sensitivity in HepG2 cells" by Y. Wang, Y.-R. Zhao, A.-Y. Zhang, J. Ma, Z.-Z. Wang, X. Zhang, published in...
9.
Wang Y, Zhao Y, Zhang A, Ma J, Wang Z, Zhang X
Eur Rev Med Pharmacol Sci
. 2017 May;
21(9):2087-2097.
PMID: 28537677
Objective: Elevated expression of caspase-8 (CASP8) and Fas-associating protein with a novel death domain (FADD)-like apoptosis regulator (CFLAR) increases sensitivity against tumor necrosis factor (TNF)-related apoptosis-inducing ligand (TRAIL)-induced cell apoptosis,...
10.
Wang B, Cao P, Wang Z, Li Z, Wang Z, Ma J, et al.
Allergy
. 2017 Mar;
72(9):1384-1397.
PMID: 28258963
Background: Autophagy is a lysosomal degradation pathway that is essential for cell survival, differentiation, and homeostasis. This study aimed to investigate the contribution of autophagy to the pathogenesis of CRS...